查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813801

全球小分子 CDMO 市場：市場規模、佔有率和趨勢分析（按產品、藥物類型、應用和地區）、細分市場預測（2025-2033 年）

Small Molecule CDMO Market Size, Share & Trends Analysis Report By Product, By Drug Type, By Application, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

小分子CDMO市場概覽

預計2024年全球小分子CDMO市場規模將達713億美元，2033年將達到1,262億美元，2025年至2033年的複合年成長率為6.7%。

市場成長是由策略外包趨勢、強勁的藥品管道和全球製造業轉變的整合所推動的。

製藥和生技公司越來越依賴CDMO來精簡研發成本、加快上市時間，並充分利用其專業能力，尤其是在高活性原料藥和複雜化學實體方面。小分子藥物（尤其是在腫瘤、感染疾病和心血管疾病等治療領域）的持續核准，支撐了對臨床和商業規模生產的強勁需求。

這個市場由不斷發展的醫藥創新和不斷變化的藥物開發經濟狀況所驅動。生物技術和虛擬製藥公司的出現正在推動市場成長，而這些公司通常缺乏內部研發、擴大規模和 GMP 製造基礎設施。這些公司不僅將 CDMO 作為供應商，還將他們作為策略合作夥伴，以便快速合規地將其分子推向市場。與過去外包以成本主導不同，如今的合約越來越以創新主導，依賴 CDMO 提供專業的製程化學、製劑科學和監管知識。這種轉變在高價值小分子的開發中尤其明顯，例如抗體藥物複合體(ADC)、HPAPI 和標靶癌症治療藥物，這些藥物面臨高度的製造複雜性和對控制的需求。

此外，CDMO生態系統中數位化和先進製造技術的日益成長也促進了市場成長。人工智慧主導的預測模型、連續流處理和即時放行測試 (RTRT) 正在改變小分子製造的成本效益和靈活性。這些技術創新使CDMO能夠在更快、數據豐富的環境中實現產品差異化、提高批量產量並滿足品質要求。此外，大型製藥公司正在尋求其供應鏈的永續性，這使得擁有綠色化學能力和低碳生產實踐的CDMO成為更具吸引力的合作夥伴。由於地緣政治不穩定和藥品短缺，供應鏈策略的區域轉變也使市場受益，促使北美製藥公司實現供應商基礎多元化，並尋找擁有冗餘產能的北美和歐洲CDMO。

目錄

第1章 分析方法與範圍

第2章執行摘要

第 3 章：小分子 CDMO 市場：促進因素、趨勢與範圍

  • 市場聯動展望
  • 小分子CDMO市場動態
  • 技術狀況
  • 定價模式分析
  • 臨床試驗量分析
  • 小分子 CDMO 市場：分析工具

第4章 小分子 CDMO 市場：按產品分類的估計與趨勢分析

  • 細分儀表板
  • 小分子CDMO市場：產品波動分析
  • 小分子 CDMO 市場：按產品分類的市場規模預測和趨勢分析（2021-2033 年）
  • 活性藥物成分（API）
  • 成品藥品

第5章 小分子 CDMO 市場：依藥物類型估算與趨勢分析

  • 細分儀表板
  • 全球小分子CDMO市場：依藥物類型分析波動
  • 全球小分子 CDMO 市場：按藥物類型分類的市場規模預測和趨勢分析（2021-2033 年）
  • 創新者
  • 學名藥

第6章：小分子 CDMO 市場：依應用估算與趨勢分析

  • 細分儀表板
  • 小分子CDMO市場：應用變化分析
  • 小分子 CDMO 市場：按應用分類的市場規模預測和趨勢分析（2021-2033 年）
  • 瘤
  • 心血管疾病
  • 中樞神經系統 (CNS) 疾病
  • 自體免疫疾病/炎症
  • 其他

第 7 章小分子 CDMO 市場：區域估計和趨勢分析（按產品、藥物類型和應用）

  • 區域市場儀表板
  • 全球市場概況：按地區
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司分類
    • 市場領導
    • 新興企業
  • 小分子 CDMO 市場佔有率/估值分析（2024 年）
  • 公司簡介
    • Lonza
    • Catalent, Inc.
    • Thermo Fisher Scientific Inc.
    • Cambrex Corporation
    • Bellen Chemistry
    • Siegfried Holding AG
    • Recipharm AB
    • Eurofins Scientific
    • Aurigene Pharmaceutical Services Ltd
    • CordenPharma International
Product Code: GVR-4-68040-165-6

Small Molecule CDMO Market Summary

The global small molecule CDMO market was estimated at USD 71.3 billion in 2024 and is projected to reach USD 126.2 billion by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The growth of the market is due to a convergence of strategic outsourcing trends, robust pharmaceutical pipelines, and global manufacturing shifts.

Pharmaceutical and biotech companies increasingly rely on CDMOs to streamline R&D costs, accelerate time-to-market, and access specialized capabilities, particularly for highly potent APIs and complex chemistries. The consistent approval of small molecule drugs, especially in therapeutic areas such as oncology, infectious diseases, and cardiology, sustains strong demand for both clinical and commercial-scale manufacturing.

The market is driven by the evolving nature of pharmaceutical innovation and the changing economic landscape of drug development. The emergence of biotech firms and virtual pharma companies, which often lack in-house infrastructure for R&D, scale up, or GMP manufacturing, is driving the market growth. These companies are turning to CDMOs not just as suppliers but as strategic collaborators to bring their molecules to market quickly and compliantly. Unlike in the past where outsourcing was cost-driven, today's engagements are increasingly innovation-driven-relying on CDMOs for specialized process chemistry, formulation science, and regulatory knowledge. This shift is particularly evident in the development of high-value small molecules such as antibody-drug conjugates (ADCs), HPAPIs, and targeted oncology drugs, where manufacturing complexity and containment needs are high.

Moreover, the growing trend towards digitalization and advanced manufacturing technologies within the CDMO ecosystem is also contributing to market growth.AI-driven predictive modeling, continuous flow processing, and real-time release testing (RTRT) are transforming the cost-efficiency and flexibility of small molecule production. These innovations allow CDMOs to differentiate their offerings, improve batch yields, and meet quality requirements in a faster, more data-rich environment. In addition, large pharmaceutical companies are seeking sustainability in their supply chains, and CDMOs with green chemistry capabilities or low-carbon production practices are becoming more attractive partners. The market is also benefiting from regional shifts in supply chain strategy due to geopolitical instability and drug shortages-prompting Western pharma firms to diversify their supplier base and seek CDMOs in North America and Europe with redundant capacity.

Global Small Molecule CDMO Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global small molecule CDMO market report based on product, drug type, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Active Pharmaceutical Ingredients (API)
  • Finished Drug Products
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Innovators
  • Generics
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular Disease
  • Central Nervous System (CNS) Conditions
  • Autoimmune/Inflammation
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Small Molecule CDMO Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Small Molecule CDMO Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trials Volume Analysis
  • 3.6. Small Molecule CDMO Market: Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Small Molecule CDMO Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Small Molecule CDMO Market Product Movement Analysis
  • 4.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Active Pharmaceutical Ingredients (API)
    • 4.4.1. Active Pharmaceutical Ingredients (API) Market Estimates and Forecasts, 2021 - 2033 (USD million)
  • 4.5. Finished Drug Products
    • 4.5.1. Finished Drug Products Market Estimates and Forecasts, 2021 - 2033 (USD million)

Chapter 5. Small Molecule CDMO Market: Drug Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Small Molecule CDMO Market Drug Type Movement Analysis
  • 5.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Drug Type, 2021 to 2033 (USD Million)
  • 5.4. Innovators
    • 5.4.1. Innovators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Generics
    • 5.5.1. Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Small Molecule CDMO Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Small Molecule CDMO Market Application Movement Analysis
  • 6.3. Global Small Molecule CDMO Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Cardiovascular Disease Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Central Nervous System (CNS) Conditions
    • 6.6.1. Central Nervous System (CNS) Conditions Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Autoimmune/Inflammation
    • 6.7.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Small Molecule CDMO Market: Regional Estimates & Trend Analysis by Product, Drug Type, Application

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Small Molecule CDMO Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Lonza
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Catalent, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Thermo Fisher Scientific Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Cambrex Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bellen Chemistry
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Siegfried Holding AG
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Recipharm AB
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Eurofins Scientific
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Aurigene Pharmaceutical Services Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CordenPharma International
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 5 North America Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 8 U.S. Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 9 Canada Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 11 Canada Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 12 Mexico Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 13 Mexico Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 14 Mexico Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 15 Europe Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 18 Europe Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 19 Germany Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 20 Germany Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 21 Germany Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 22 UK Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 23 UK Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 24 UK Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 25 France Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 26 France Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 27 France Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 28 Italy Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 29 Italy Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 30 Italy Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 31 Spain Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 32 Spain Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 33 Spain Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 34 Denmark Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 35 Denmark Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 36 Denmark Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 37 Sweden Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 38 Sweden Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 39 Sweden Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 40 Norway Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 41 Norway Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 42 Norway Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 47 China Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 48 China Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 49 China Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 50 Japan Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 51 Japan Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 52 Japan Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 53 India Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 54 India Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 55 India Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 56 South Korea Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 57 South Korea Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 58 South Korea Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 59 Australia Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 60 Australia Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 61 Australia Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 62 Thailand Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 63 Thailand Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 64 Thailand Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 65 Latin America Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 66 Latin America Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 67 Latin America Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 68 Latin America Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 69 Brazil Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 70 Brazil Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 71 Brazil Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 72 Argentina Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 73 Argentina Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 74 Argentina Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 75 MEA Small Molecule CDMO market, by region, 2021 - 2033 (USD Million)
  • Table 76 MEA Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 77 MEA Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 78 MEA Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 79 South Africa Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 80 South Africa Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 81 South Africa Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 85 UAE Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 86 UAE Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 87 UAE Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)
  • Table 88 Kuwait Small Molecule CDMO market, by product, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Small Molecule CDMO market, by drug type, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Small Molecule CDMO market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Small Molecule CDMO market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 Small Molecule CDMO market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Small Molecule CDMO market Product outlook: Segment dashboard
  • Fig. 22 Small Molecule CDMO market, by Product segment: Market share, 2025 & 2033
  • Fig. 23 Active Pharmaceutical Ingredients (API) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Finished Drug Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Small Molecule CDMO market Drug Type outlook: Segment dashboard
  • Fig. 26 Small Molecule CDMO market, by Drug Type segment: Market share, 2024 & 2033
  • Fig. 27 Innovators market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Generics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Small Molecule CDMO market Application outlook: Segment dashboard
  • Fig. 30 Small Molecule CDMO market, by Application segment: Market share, 2024 & 2033
  • Fig. 31 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cardiovascular Disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Central Nervous System (CNS) Conditions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Autoimmune/Inflammation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Regional market: Key takeaways
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 U.S. Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Canada Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Mexico Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 UK Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Germany Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 France Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Italy Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Spain Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Sweden Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 China Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 India Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 South Korea Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Thailand Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Brazil Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Argentina Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 MEA Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Africa Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Saudi Arabia Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 UAE Small Molecule CDMO market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Market participant categorization
  • Fig. 90 Heat map analysis